Showing results (481-490 of 21,387) with videos related to
Sort By:
Pageof 2,139
The Journal of Experimental Medicine|December 1, 1975
A mechanism for the induction of immunological tolerance by antigen feeding: antigen-antibody complexesC André, J F Heremans, J P Vaerman, et al.The Journal of Experimental Medicine|November 2, 1999
Defects in hemopoietic stem cell activity in Ikaros mutant miceA Nichogiannopoulou, M Trevisan, S Neben, et al.The Journal of Experimental Medicine|November 2, 1999
Human transporters associated with antigen processing (TAPs) select epitope precursor peptides for processing in the endoplasmic reticulum and presentation to T cellsG Lauvau, K Kakimi, G Niedermann, et al.The Journal of Experimental Medicine|November 2, 1999
Impaired NK1.1 T cell development in mice transgenic for a T cell receptor beta chain lacking the large, solvent-exposed cbeta FG loopS Degermann, G Sollami, K KarjalainenThe Journal of Experimental Medicine|November 9, 2000
Complement C4 inhibits systemic autoimmunity through a mechanism independent of complement receptors CR1 and CR2Z Chen, S B Koralov, G KelsoeThe Journal of Experimental Medicine|October 4, 2000
CD1b-mediated T cell recognition of a glycolipid antigen generated from mycobacterial lipid and host carbohydrate during infectionD B Moody, M R Guy, E Grant, et al.The Journal of Experimental Medicine|October 4, 2000
Tec family kinases modulate thresholds for thymocyte development and selectionE M Schaeffer, C Broussard, J Debnath, et al.The Journal of Experimental Medicine|October 4, 2000
LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cellsDe Yang, Q Chen, A P Schmidt, et al.The Journal of Experimental Medicine|September 20, 2000
Development of a peptide inhibitor of hyaluronan-mediated leukocyte traffickingM E Mummert, M Mohamadzadeh, D I Mummert, et al.The Journal of Experimental Medicine|September 20, 2000
DM determines the cryptic and immunodominant fate of T cell epitopesN K Nanda, A J SantPageof 2,139